DINUTUXIMAB

UNII:	7SQY4ZUD30
Type:	INGREDIENT SUBSTANCE
Formula:
Preferred Substance Name:	DINUTUXIMAB
GSRS Full Record:	7SQY4ZUD30 i

1363687-32-4
APN-311
APN311
CH-14.18
CH-14.18-UTC
CH-1418
CH14.18
CH14.18-UTC
CH1418
CHIMERIC ANTI-DISIALOGANGLIOSIDE (GD2) MONOCLONAL ANTIBODY (CH14.18/CHO)
DINUTUXIMAB BETA
DINUTUXIMAB [JAN]
DINUTUXIMAB [MI]
DINUTUXIMAB [PURPLE BOOK CDER]
DINUTUXIMAB [USAN]
Dinutuximab [WHO-DD]
Dinutuximab beta [WHO-DD]
IMMUNOGLOBULIN G1, ANTI-(GANGLIOSIDE GD2) (HUMAN-MUS MUSCULUS MONOCLONAL CH14.18 HEAVY CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL CH14.18 LIGHT CHAIN, DIMER
IMMUNOGLOBULIN G1, ANTI-(GANGLIOSIDE GD2) (HUMAN-MUS MUSCULUS MONOCLONAL CH14.18/CHO HEAVY CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL CH14.18/CHO LIGHT CHAIN, DIMER
QARZIBA
UNITUXIN
dinutuximab [INN]
dinutuximab beta [INN]

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

DINUTUXIMAB

Synonyms and Mappings

Resources